<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05068180</url>
  </required_header>
  <id_info>
    <org_study_id>KY2020-125</org_study_id>
    <nct_id>NCT05068180</nct_id>
  </id_info>
  <brief_title>Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients</brief_title>
  <official_title>Low-dose Neuroleptanalgesia Reduce the Occurrences of Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Major Surgery : a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai 8th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative delirium（POD）is a common complication that can directly affect important&#xD;
      clinical outcomes, and exert an enormous burden on patients, their families, hospitals, and&#xD;
      public resources. In order to evaluate whether an intraoperative administration of low-dose&#xD;
      neuroleptanalgesia reduces postoperative delirium, droperidol 1.25 mg and fentanyl 0.025 mg&#xD;
      or normal saline is used by intravenous injection 30 minutes before the end of the operation,&#xD;
      in elderly patients with non-cardiac major surgery under general anesthesia. The efficiency&#xD;
      and safety of neuroleptanalgesia on the incidence of POD would be evaluated in elderly&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 5, 2021</start_date>
  <completion_date type="Anticipated">April 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 10, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidences of POD after general anesthesia in elderly patients undergoing non-cardiac major surgery</measure>
    <time_frame>Up to 7 days after surgery（or leaving hospital）</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative nausea and vomiting</measure>
    <time_frame>Up to 7 days after surgery（or leaving hospital）</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' satisfaction</measure>
    <time_frame>Up to 7 days after surgery（or leaving hospital）</time_frame>
    <description>This outcome will be measured using a numeric rating scale from 1 ( dissatisfaction ) to 3 (very satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative hypoxia</measure>
    <time_frame>Up to 1 day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major serious complications and serious arrhythmia</measure>
    <time_frame>Up to 7 days after surgery（or leaving hospital）</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of postoperative delirium</measure>
    <time_frame>Up to 7 days after surgery（or leaving hospital）</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Stomach Neoplasms</condition>
  <condition>Colonic Neoplasms</condition>
  <condition>Rectal Neoplasms</condition>
  <condition>Sigmoid Neoplasms</condition>
  <condition>Liver Neoplasms</condition>
  <condition>Kidney Neoplasms</condition>
  <condition>Urinary Bladder Neoplasms</condition>
  <condition>Prostatic Neoplasms</condition>
  <condition>Osteoarthropathy</condition>
  <condition>Fractures, Bone</condition>
  <condition>Gynecologic Cancer</condition>
  <arm_group>
    <arm_group_label>Neuroleptanalgesia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Droperidol 1.25 mg and fentanyl 0.025 mg (diluted with normal saline up to 5ml) is to be administrated intravenously 30 minutes before the end of the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The same volume of normal saline is to be administrated intravenously 30 minutes before the end of the procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>low-dose neuroleptanalgesia</intervention_name>
    <description>Droperidol 1.25 mg and fentanyl 0.025 mg (diluted with normal saline up to 5ml) is to be administrated intravenously 30 minutes before the end of the procedure.</description>
    <arm_group_label>Neuroleptanalgesia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The same volume of normal saline is to be administrated intravenously 30 minutes before the end of the procedure.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥ 65 years old and ≤ 85 years old;&#xD;
&#xD;
          2. Selective non-cardiac major surgery;&#xD;
&#xD;
          3. Informed consent and voluntary participation in the trial;&#xD;
&#xD;
          4. ASA class I-II;&#xD;
&#xD;
          5. Anticipated operation duration ≥ 2 hours;&#xD;
&#xD;
          6. No plan to ICU after operation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Neurosurgery;&#xD;
&#xD;
          2. Patients with neurological and mental diseases: such as basal ganglia disease,&#xD;
             Parkinson's syndrome, severe central nervous depression, Alzheimer's disease , etc;&#xD;
&#xD;
          3. Patients with prolonged Q-T interval, cardiac repolarization disorder and other severe&#xD;
             arrhythmia;&#xD;
&#xD;
          4. Patients with severe cardiopulmonary disease, liver and kidney dysfunction;&#xD;
&#xD;
          5. Allergic or contraindications to droperidol or fentanyl citrate;&#xD;
&#xD;
          6. Admitted to ICU after operation.&#xD;
&#xD;
          7. Operation duration &lt; 2 hours;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diansan Su, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>RenJi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diansan Su, Doctor</last_name>
    <phone>18616514088</phone>
    <email>184872238@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhenling Huang, Doctor</last_name>
    <phone>18964381971</phone>
    <email>2993252569@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenling Huang, Doctor</last_name>
      <phone>18964381971</phone>
      <email>2993252569@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiao Zhang, MS</last_name>
      <phone>18317087118</phone>
      <email>fdzhangxiao@126.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shanghai Eighth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cuixia Song, BS</last_name>
      <phone>13817874048</phone>
      <email>songcuixia2001@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 6, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postoperative delirium</keyword>
  <keyword>Neuroleptanalgesia</keyword>
  <keyword>Aged</keyword>
  <keyword>Noncardiac major surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Sigmoid Neoplasms</mesh_term>
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

